Valuation (84%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.02 | N/A |
| PEG Ratio (TTM) | 0.07 | N/A |
| P/S Ratio (TTM) | 435.15 | N/A |
| P/B Ratio (TTM) | 3.04 | N/A |
| P/FCF Ratio (TTM) | 6.08 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.68 | N/A |
| Price to 5YR AVG FCF Ratio | 9.17 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 15.70% | N/A |
| ROE (TTM) | 47.14% | N/A |
| Net Profit Margin (TTM) | 6,190.57% | N/A |
| ROIC 5YR AVG | 20.40% | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.41% | 158.12% | 125.40% |
| Revenue | -5.36% | -7.04% | -23.35% |
| Net Income | -5.24% | 150.28% | 116.32% |
| Cash Flow | 11.85% | 576.58% | 368.66% |
Health (89%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.01 | N/A |
| Quick Ratio (TTM) | 1.42 | N/A |
| D/E Ratio (TTM) | 0.37 | N/A |
| Interest Coverage (TTM) | 24.11 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 5.96 | N/A |
| LTL to 5YR AVG FCF | 1.05 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.02% | N/A |